A San Francisco bank specializing in the biotechnology industry said biotech stocks showed improvement in August. The CEO of Burrill & Co. said that unlike general markets, "biotech managed to reverse its downward trend" when the Burrill Biotech Select Index posted a 2% gain. "The biotech market seems to have hit its bottom and we can expect to see values continue to grow in September, albeit slowly" he said.

Related Summaries